-
公开(公告)号:US20220008413A1
公开(公告)日:2022-01-13
申请号:US17193795
申请日:2021-03-05
IPC分类号: A61K31/496
摘要: The present invention is directed to a combination therapy involving a type II anti-CD20 antibody and a selective Bcl-2 inhibitor for the treatment of a patient suffering from cancer, particularly, a CD20-expressing cancer.
-
公开(公告)号:US20210401621A1
公开(公告)日:2021-12-30
申请号:US16760289
申请日:2018-11-02
发明人: Maxime GAILLOT , Roberta LEAH , Declan REILLY , Thomas THUEER , Jack CARROLL , James COOP , Edward SIMS , Mark TEUCHER
IPC分类号: A61F9/00
摘要: A device for providing a droplet of a liquid stored in an interior of a vial is disclosed that includes a support body and a resilient dome portion mounted to the support body to form a chamber having air, with the dome portion being configured to create an air flow when activated by compression. The support body includes a vial seat, a nozzle, and air flow and transfer conduits. The support body is arranged, when the vial is received by the vial seat, such that the air flow conduit establishes an air connection between the vial interior and the chamber, the transfer conduit establishes a fluid connection between the vial and the nozzle, and, upon activation of the dome portion, the air flow delivers air into the vial that causes liquid to be transferred from the vial to the nozzle through the transfer conduit.
-
公开(公告)号:US20210395239A1
公开(公告)日:2021-12-23
申请号:US17278416
申请日:2019-09-25
发明人: Fabian DEY , Jianguo CHEN , Haixia LIU , Yafei LIU , Hong SHEN , Weixing ZHANG , Zhiwei ZHANG , Wei ZHU
IPC分类号: C07D413/14 , C07D498/08 , C07D498/10 , C07D471/04
摘要: The present invention relates to compounds of formula (I), wherein R1 to R3, A and Q are as described herein, and their pharmaceutically acceptable salt, enantiomer or diastereomer thereof, and compositions including the compounds and methods of using the compounds.
-
公开(公告)号:US20210381608A1
公开(公告)日:2021-12-09
申请号:US17406782
申请日:2021-08-19
发明人: Jennifer Römer , Christian Neusüss
IPC分类号: F16K11/074 , G01N30/20 , F16K31/04
摘要: A fluid transfer valve has ports arranged in groups. The valve has a rotor having channels and an actuator is operably connectable to the rotor. The actuator is positionable in a loading orientation in which the first channel is connected to one or two of the ports to transfer fluid into the first channel and/or the second channel is connected to one or two of the ports to transfer a second fluid into the second channel. The actuator also is positionable into first and second injection orientations in which various ones of the channels and ports are connected for different fluid flow configurations. Each channel has two ends located on a virtual circle whose center coincides with the rotor's axis of rotation. The channels can have a semicircular shape, a semi-oval shape or a U-shape. An analytical system and method that use the inventive valve are also disclosed.
-
公开(公告)号:US20210355234A1
公开(公告)日:2021-11-18
申请号:US17443893
申请日:2021-07-28
发明人: Christian KLEIN , Marina BACAC , Anne FREIMOSER-GRUNDSCHOBER , Sylvia HERTER , Joaquin ARRIBAS , Rocio VICARIO
摘要: The present invention generally relates to novel bispecific antigen binding molecules for T cell activation and re-direction to specific target cells. In addition, the present invention relates to polynucleotides encoding such bispecific antigen binding molecules, and vectors and host cells comprising such polynucleotides. The invention further relates to methods for producing the bispecific antigen binding molecules of the invention, and to methods of using these bispecific antigen binding molecules in the treatment of disease.
-
公开(公告)号:US20210347800A1
公开(公告)日:2021-11-11
申请号:US17236501
申请日:2021-04-21
发明人: Joerg LILL , Filippo SLADOJEVICH
摘要: The invention relates to a new process for the purification of oligonucleotides which comprises the removal of the acid labile 5′hydroxy protecting group at the 5′-O-oligonucleotide terminus of the oligonucleotide by way of tangential flow filtration with an acidic buffer solution. The process requires less steps and allows a higher degree of automation.
-
公开(公告)号:US20210323977A1
公开(公告)日:2021-10-21
申请号:US17272548
申请日:2018-08-28
发明人: HAIXIA LIU , GUOLONG WU , WEIXING ZHANG , WEI ZHU , HONG SHEN , FABIAN DEY
IPC分类号: C07D498/18 , C07D413/14 , C07D413/04 , C07D487/10 , C07D471/04 , C07D403/04 , C07D471/10 , C07D471/08 , C07D401/14
摘要: The present invention relates to compounds of formula (I) wherein R1, R2, R3 and R4 are as described herein, and their pharmaceutically acceptable salt, enantiomer or diastereomer thereof, and compositions including the compounds and methods of using the compounds.
-
公开(公告)号:US20210300947A1
公开(公告)日:2021-09-30
申请号:US17251494
申请日:2019-06-11
发明人: FABIAN DEY , BUYU KOU , HAIXIA LIU , HONG SHEN , XIAOQING WANG , WEIXING ZHANG , ZHISEN ZHANG , ZHIWEI ZHANG , WEI ZHU
IPC分类号: C07D519/00 , C07D487/04 , C07D413/14 , C07D417/14 , C07D471/04 , C07D498/10
摘要: The present invention relates to compounds of formula (I), ab (I), wherein R1 to R3 and L are as described herein, and their pharmaceutically acceptable salt, enantiomer or diastereomer thereof, and compositions including the compounds and methods of using the compounds.
-
公开(公告)号:US20210284648A1
公开(公告)日:2021-09-16
申请号:US17337547
申请日:2021-06-03
发明人: Benno Rothenhaeusler , Rene Trussardi , Fabienne Hoffmann-Emery , Urs Schwitter , Jean-Michel Adam , Olaf Grassmann , Thomas Hartung , Frederic Ran , Ralph Diodone , Christophe Pfleger , Bjorn Bartels
IPC分类号: C07D487/04 , C07D243/14
摘要: The invention provides processes to manufacture substituted 1-[4-(Pyridin-2-yloxy)-cyclohexyl]-5,6-dihydro-4H-2,3,5,10b-tetraaza-benzo[e]azulenes. Also disclosed are compounds useful as intermediates in the methods of the invention.
-
公开(公告)号:US20210270828A1
公开(公告)日:2021-09-02
申请号:US17324985
申请日:2021-05-19
发明人: Stephen FOWLER , Na Hong QIU , Guojun CHEN
IPC分类号: G01N33/543 , G01N33/50
摘要: The present invention provides a method for attaching cells to a biosensor surface (5) of a biosensor (4) comprising: providing a cell suspension in a liquid receiving unit (1), wherein the cell suspension forms a surface (7) to the exterior of the liquid receiving unit (1); contacting the biosensor surface (5) with the surface (7) of the cell suspension in the liquid receiving unit (1); and allowing the cells to settle on the biosensor surface (5) by gravity, and allowing the cells to adhere to the biosensor surface (5).
-
-
-
-
-
-
-
-
-